Literature DB >> 22646253

Screening for colorectal cancer: what fits best?

Chun Seng Lee1, Leen Ronan, Colm O'Morain, Deirdre McNamara.   

Abstract

Colorectal cancer (CRC) screening has been shown to be effective in reducing CRC incidence and mortality. There are currently a number of screening modalities available for implementation into a population-based CRC screening program. Each screening method offers different strengths but also possesses its own limitations as a population-based screening strategy. We review the current evidence base for accepted CRC screening tools and evaluate their merits alongside their challenges in fulfilling their role in the detection of CRC. We also aim to provide an outlook on the demands of a low-risk population-based CRC screening program with a view to providing insight as to which modality would best suit current and future needs.

Entities:  

Mesh:

Year:  2012        PMID: 22646253     DOI: 10.1586/egh.12.12

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  5 in total

1.  Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).

Authors:  Miroslava Katičić; Nataša Antoljak; Milan Kujundžić; Valerija Stamenić; Dunja Skoko Poljak; Danica Kramarić; Davor Stimac; Marija Strnad Pešikan; Mirko Samija; Zdravko Ebling
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

Review 2.  Colorectal cancer screening: tests, strategies, and perspectives.

Authors:  Fabrizio Stracci; Manuel Zorzi; Grazia Grazzini
Journal:  Front Public Health       Date:  2014-10-27

3.  Demographic characteristics and the first program of colorectal cancer (CRC) screening in north of Iran (2016).

Authors:  Hossein-Ali Nikbakht; Haleh Ghaem; Javad Shokri-Shirvani; Saber Ghaffari-Fam; Sedigheh Alijanpour
Journal:  J Gastrointest Oncol       Date:  2018-06

4.  Human Blood Autoantibodies in the Detection of Colorectal Cancer.

Authors:  Ola H Negm; Mohamed R Hamed; Robert E Schoen; Richard L Whelan; Robert J Steele; John Scholefield; Elizabeth M Dilnot; H M C Shantha Kumara; John F R Robertson; Herbert F Sewell
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

5.  Diagnostic value of platelet-lymphocyte ratio and hemoglobin-platelet ratio in patients with rectal cancer.

Authors:  Cui-Ju Mo; Zuo-Jian Hu; Shan-Zi Qin; Hua-Ping Chen; Li Huang; Shan Li; Zhao Cao
Journal:  J Clin Lab Anal       Date:  2020-01-20       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.